Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China flag China · Delayed Price · Currency is CNY
35.70
+1.41 (4.11%)
Apr 15, 2026, 3:04 PM CST

SHE:002422 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
6,0323,9744,6754,7292,920
Short-Term Investments
635.45555.65579.39--
Trading Asset Securities
1,4571,9211,691448.11359.53
Cash & Short-Term Investments
8,1246,4516,9465,1773,279
Cash Growth
25.95%-7.13%34.17%57.88%7.96%
Accounts Receivable
6,0076,0986,1207,1986,463
Other Receivables
82.69126.17162.49256.3221.92
Receivables
6,0906,2246,2837,4546,685
Inventory
3,8473,8013,8403,2143,363
Other Current Assets
1,9781,4601,222804.22681.4
Total Current Assets
20,04017,93618,29016,64914,009
Property, Plant & Equipment
13,07413,01212,08611,33111,614
Long-Term Investments
4,6244,2813,9923,8093,409
Goodwill
96.2598.6698.6698.6698.66
Other Intangible Assets
1,2261,2231,2771,2011,063
Long-Term Deferred Tax Assets
455.25423.03342.57618.21581.57
Long-Term Deferred Charges
90.8783.0675.72233.81365.28
Other Long-Term Assets
228.74260.11293.17264.34400.05
Total Assets
39,83537,31636,45534,20631,540
Accounts Payable
2,5332,5742,5392,2442,156
Accrued Expenses
1,9642,2592,0281,9731,610
Short-Term Debt
3,2612,4573,4584,4995,183
Current Portion of Long-Term Debt
151.15808.4746.862,0123,199
Current Portion of Leases
60.7362.5640.5317.3111.57
Current Income Taxes Payable
125.74140.11162.74108.18119.48
Current Unearned Revenue
563.13645.45839.83360.36264.69
Other Current Liabilities
531.61190.71177.87889.3864.55
Total Current Liabilities
9,1909,1389,99312,10413,408
Long-Term Debt
191.13422,6494,7043,506
Long-Term Leases
544.46537.46245.2351.7416.18
Long-Term Unearned Revenue
326.81294.65288.21208.88225.73
Long-Term Deferred Tax Liabilities
285.2266.09264.1265.83254.32
Other Long-Term Liabilities
3.74-0.08--
Total Liabilities
10,54110,57813,43917,33517,410
Common Stock
1,5981,6011,4991,4221,425
Additional Paid-In Capital
8,7687,7326,1443,6733,581
Retained Earnings
13,92413,22211,97310,4169,328
Treasury Stock
-131.7-191.83-215.14-237.08-399.98
Comprehensive Income & Other
66.39115.84272.07459.82-77.49
Total Common Equity
24,22422,48019,67215,73413,857
Minority Interest
5,0694,2593,3431,137272.62
Shareholders' Equity
29,29426,73823,01616,87114,129
Total Liabilities & Equity
39,83537,31636,45534,20631,540
Total Debt
4,2084,2077,13911,28511,916
Net Cash (Debt)
3,9162,243-193.52-6,108-8,637
Net Cash Growth
74.58%----
Net Cash Per Share
2.461.42-0.13-4.12-6.11
Filing Date Shares Outstanding
1,5901,5911,4881,4121,406
Total Common Shares Outstanding
1,5901,5911,4881,4121,406
Working Capital
10,8508,7988,2974,545600.44
Book Value Per Share
15.2314.1313.2211.159.85
Tangible Book Value
22,90221,15818,29714,43412,695
Tangible Book Value Per Share
14.4013.3012.2910.239.03
Buildings
7,6657,4646,5576,1606,057
Machinery
13,79213,10111,59211,34811,078
Construction In Progress
1,5041,2042,0451,126922.73
Source: S&P Global Market Intelligence. Standard template. Financial Sources.